Therapeutic Effect of Intratracheal Administration of Murine IL-4 Receptor Antagonist on Asthmatic Airway Inflammation

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Asthma

• Publication date

  2008-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/02770900802252085PMID 18951266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Persistent effects induced by IL-13 in the lung.

  2006cited by this paper
• IL-4 Receptor α Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets1

  2006influential reference
• IL-4 induces IL-13-independent allergic airway inflammation.

  2006cited by this paper
• Alterations in T-Lymphocyte Subsets in the Airways of Asthmatic Patients with Active Hepatitis C Virus Infection

  2006cited by this paper
• IL-13 effector functions.

  2003cited by this paper
• Treatment of experimental asthma by long-term gene therapy directed against IL-4 and IL-13.

  2003cited by this paper
• A single administration of interleukin-4 antagonistic mutant DNA inhibits allergic airway inflammation in a mouse model of asthma

  2003cited by this paper
• Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice

  2002cited by this paper
• Tryptase Inhibition Blocks Airway Inflammation in a Mouse Asthma Model1

  2002cited by this paper
• A Murine IL-4 Receptor Antagonist That Inhibits IL-4- and IL-13-Induced Responses Prevents Antigen-Induced Airway Eosinophilia and Airway Hyperresponsiveness1

  2001cited by this paper
• Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

  2001cited by this paper
• Distribution and cytokine production of CD4 and CD8 T-lymphocyte subsets in patients with acute asthma attacks.

  2001cited by this paper
• The IL-4 receptor: signaling mechanisms and biologic functions.

  1999cited by this paper
• Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling.

  1999cited by this paper
• The role of IL-13 and its receptor in allergy and inflammatory responses.

  1998influential reference
• STAT6 Is Required for the Anti-inflammatory Activity of Interleukin-4 in Mouse Peritoneal Macrophages*

  1998cited by this paper
• An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo.

  1998cited by this paper
• Lymphocyte subtypes in asthma: relationship with the clinical status and bronchial hyperreactivity.

  1998cited by this paper
• Controlling chemical reactivity with antibodies

  1993cited by this paper
• IL-12: initiation cytokine for cell-mediated immunity.

  1993cited by this paper
• Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

  1993cited by this paper

• Gene Therapy for Immunoglobulin E, Complement-Mediated, and Eosinophilic Disorders

  2023cites this paper
• LPS Exposure in Early Life Protects Against Mucus Hypersecretion in Ovalbumin-Induced Asthma by Down-Regulation of the IL-13 and JAK-STAT6 Pathways

  2018cites this paper
• Genetic Modification of the Lung Directed Toward Treatment of Human Disease

  2017cites this paper
• Vitamin A maintains the airway epithelium in a murine model of asthma by suppressing glucocorticoid‐induced leucine zipper

  2016cites this paper
• Asthma research in China: A five‐year review

  2013cites this paper
• Targeting interleukin-4 in asthma: lost in translation?

  2012cites this paper
• Investigation of the interaction between CREB-binding protein and STAT4/STAT6

  2011cites this paper
• Gene Therapy for Allergic Airway Diseases

  2011cites this paper